PCN95 The Cost-Effectiveness of Aprepitant for the Prevention of Nausea and Vomiting Induced by Moderately Emetogenic Chemotherapy in Breast Cancer Patients Compared to Current Clinical Practice in Scotland

Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1196
https://www.valueinhealthjournal.com/article/S1098-3015(11)02758-6/fulltext
Title : PCN95 The Cost-Effectiveness of Aprepitant for the Prevention of Nausea and Vomiting Induced by Moderately Emetogenic Chemotherapy in Breast Cancer Patients Compared to Current Clinical Practice in Scotland
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02758-6&doi=10.1016/j.jval.2011.08.1196
First page : A451
Section Title : Cancer
Open access? : No
Section Order : 1153
Categories :
Tags :
Regions :
ViH Article Tags :